Australia's rollout of the AstraZeneca vaccine will continue despite growing fears the jab could be related to a blood clotting condition reported in some patients.
Acting Chief Medical Officer Michael Kidd has dismissed suggestions the vaccine poses any serious threat and the government's medical advice remains unchanged despite a man being hospitalised with a rare blood clotting condition after receiving it.
'The society recommends that benefits outweigh the risks of COVID-19 vaccination and the society's advice is that individuals should continue taking the offer of COVID-19 vaccination,' Professor Kidd said on Saturday.
'The risks of serious side effects remain very low. But safety is paramount, which is why ATAGI and the TGA continue to do due diligence on this case.